Association of the resolvin precursor 17-HDHA, but not D- or E- series resolvins, with heat pain sensitivity and osteoarthritis pain in humans

[1]  D. Barrett,et al.  Targeting the D Series Resolvin Receptor System for the Treatment of Osteoarthritis Pain , 2017, Arthritis & rheumatology.

[2]  S. Tunaru,et al.  The leukotriene B4 receptors BLT1 and BLT2 form an antagonistic sensitizing system in peripheral sensory neurons , 2017, The Journal of Biological Chemistry.

[3]  S. Spinelli,et al.  Maresin 1 induces a novel pro‐resolving phenotype in human platelets , 2017, Journal of thrombosis and haemostasis : JTH.

[4]  D. Mohapatra,et al.  Nociceptive TRP Channels: Sensory Detectors and Transducers in Multiple Pain Pathologies , 2016, Pharmaceuticals.

[5]  S. Hwang,et al.  Modulation of the Activities of Neuronal Ion Channels by Fatty Acid-Derived Pro-Resolvents , 2016, Front. Physiol..

[6]  J. Calixto,et al.  EPA- and DHA-derived resolvins' actions in inflammatory bowel disease. , 2016, European journal of pharmacology.

[7]  T. Itoh,et al.  17-OxoDHA Is a PPAR alpha/gamma Dual Covalent Modifier and Agonist , 2016 .

[8]  T. Itoh,et al.  17-OxoDHA Is a PPARα/γ Dual Covalent Modifier and Agonist. , 2016, ACS chemical biology.

[9]  D. Irimia,et al.  Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis , 2016, JCI insight.

[10]  L. March,et al.  Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose , 2015, Annals of the rheumatic diseases.

[11]  J. McDougall,et al.  Mechanisms and Mediators That Drive Arthritis Pain , 2015, Current Osteoporosis Reports.

[12]  Pasi Soininen,et al.  Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. , 2015, Circulation. Cardiovascular genetics.

[13]  D. Clauw,et al.  The impact of pain on systemic rheumatic diseases. , 2015, Best practice & research. Clinical rheumatology.

[14]  D. Barrett,et al.  Simultaneous tissue profiling of eicosanoid and endocannabinoid lipid families in a rat model of osteoarthritis[S] , 2014, Journal of Lipid Research.

[15]  C. Serhan,et al.  Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. , 2014, American journal of physiology. Cell physiology.

[16]  Charles N. Serhan,et al.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[17]  Kamran Moradi,et al.  Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea‐predominant irritable bowel syndrome: Role of nitric oxide , 2014, Clinical and experimental pharmacology & physiology.

[18]  S. Hwang,et al.  Resolvins: Endogenously-Generated Potent Painkilling Substances and their Therapeutic Perspectives , 2013, Current neuropharmacology.

[19]  Alireza Moayyeri,et al.  COHORT PROFILE Cohort Profile : TwinsUK and Healthy Ageing Twin Study , 2013 .

[20]  T. Spector,et al.  Genes Contributing to Pain Sensitivity in the Normal Population: An Exome Sequencing Study , 2012, PLoS genetics.

[21]  Quan-xin Feng,et al.  Resolvin D1 reverses chronic pancreatitis-induced mechanical allodynia, phosphorylation of NMDA receptors, and cytokines expression in the thoracic spinal dorsal horn , 2012, BMC Gastroenterology.

[22]  S. Bae,et al.  Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis. , 2012, Archives of medical research.

[23]  S. Hwang,et al.  17(R)‐resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception , 2012, British journal of pharmacology.

[24]  C. Serhan,et al.  Emerging roles of resolvins in the resolution of inflammation and pain , 2011, Trends in Neurosciences.

[25]  T. Spector,et al.  The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis , 2011, Annals of the rheumatic diseases.

[26]  A. Szallasi,et al.  TRP channels and pain. , 2009, Current pharmaceutical design.

[27]  D. Barrett,et al.  Quantitative profiling of epoxyeicosatrienoic, hydroxyeicosatetraenoic, and dihydroxyeicosatetraenoic acids in human intrauterine tissues using liquid chromatography/electrospray ionization tandem mass spectrometry. , 2007, Analytical biochemistry.

[28]  R. F. Roberts,et al.  Comparison of serum and heparinized plasma samples for measurement of chemistry analytes. , 2004, Clinical chemistry.

[29]  N. Bellamy,et al.  Outcome measurement in osteoarthritis clinical trials: The case for standardisation , 1984, Clinical Rheumatology.

[30]  J. Kellgren,et al.  Genetic Factors in Generalized Osteo-Arthrosis , 1963, Annals of the rheumatic diseases.

[31]  S. Perrot.  Osteoarthritis pain. , 2015, Best practice & research. Clinical rheumatology.

[32]  F. Berenbaum,et al.  Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). , 2013, Osteoarthritis and cartilage.